[Therapy of primary chronic glomerulonephritis].
Primary chronic glomerulonephritis may emerge clinically as acute nephritis, the nephrotic syndrome as well as asymptomatic hematuria and proteinuria. Therapeutic consequences still depend on the morphological diagnosis. In cases of minor proteinuria [< 3,5 g/24 h] immunosuppressive therapy is not superior to symptomatic therapy. In patients with nephrotic syndrome immunosuppressive therapy depends on the morphological diagnosis. Glucocorticoids are the therapy of choice in minimal changes glomerulopathy and should be tried in focal segmental sclerosing glomerulonephritis. Steroids may be tried in pure mesangial as well as in IgA and IgM nephropathy. Especially Ponticelli claims significant therapeutic success in patients with membranous glomerulonephritis treated with Prednisolone and Chlorambucil. Failures and relapses may be treated with Cyclophosphamide, Chlorambucil or Cyclosporin A. Anticoagulants may be advantageous in the therapy of membranoproliferative glomerulonephritis.
Risler
T
T
Sektion Nieren- und Hochdruckkrankheiten, Medizinischen Universitätsklinik Tübingen.
Braun
N
N
Erley
C M
CM
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005921:Glomerulonephritis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000175:diagnosis; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology; D009402:Nephrosis, Lipoid / Q000175:diagnosis; D009404:Nephrotic Syndrome / Q000150:complications
D000806:Angiotensin-Converting Enzyme Inhibitors; D007166:Immunosuppressive Agents
Therapie der primär-chronischen Glomerulonephritis.